1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Skin Cancer-Pipeline Insights, 2017

Skin Cancer-Pipeline Insights, 2017

  • January 2017
  • -
  • Delve Insight


DelveInsight’s, “ Skin Cancer-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Skin Cancer. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Skin Cancer. DelveInsight’s Report also assesses the Skin Cancer therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope

- The report provides competitivepipeline landscape of Skin Cancer
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Skin Cancer pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Skin Cancer and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Skin Cancer-Pipeline Insights, 2017
Illustrative

- Skin Cancer Overview
- Skin Cancer Pipeline Therapeutics
- Skin Cancer Therapeutics under Development by Companies
- Skin Cancer Filed and Phase III Products
- Comparative Analysis
- Skin Cancer Phase II Products
- Comparative Analysis
- Skin Cancer Phase I and IND Filed Products
- Comparative Analysis
- Skin Cancer Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Skin Cancer - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Skin Cancer - Discontinued Products
- Skin Cancer - Dormant Products
- Companies Involved in Therapeutics Development for Skin Cancer
- Appendix
- Methodology
- Contact Us
- Disclaimer


List of Tables

- Number of Products under Development for Skin Cancer, 2017
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2017
- Comparative Analysis Phase II Products, 2017
- Comparative Analysis Phase I and IND Filed Products, 2017
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017
- Drug Candidates Profiles
- Skin Cancer Assessment by Monotherapy Products
- Skin Cancer Assessment by Combination Products
- Skin Cancer Assessment by Route of Administration
- Skin Cancer Assessment by Stage and Route of Administration
- Skin Cancer Assessment by Molecule Type
- Skin Cancer Assessment by Stage and Molecule Type
- Skin Cancer Therapeutics - Discontinued Products
- Skin Cancer Therapeutics - Dormant Products
- Products under Development by Companies, 2017


List of Figures

- Number of Products under Development for Skin Cancer, 2017
- Filed and Phase III Products, 2017
- Phase II Products, 2017
- Phase I and IND Filed Products, 2017
- Discovery and Pre-Clinical Stage Products, 2017
- Skin Cancer Assessment by Monotherapy Products
- Skin Cancer Assessment by Combination Products
- Skin Cancer Assessment by Route of Administration
- Skin Cancer Assessment by Stage and Route of Administration
- Skin Cancer Assessment by Molecule Type
- Skin Cancer Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Global Skin Cancer Therapeutics Market - Growth, Trends and Forecasts (2016 - 2021)

Global Skin Cancer Therapeutics Market - Growth, Trends and Forecasts (2016 - 2021)

  • $ 4250
  • Industry report
  • October 2016
  • by Mordor Intelligence LLP

The global skin cancer treatment market is expected to grow at a CAGR of XX% during the forecast period 2016-2021. The market was valued at USD XX million in 2015 and is forecasted to reach USD XX million ...

Implantable Infusion Pumps Market Analysis & Trends- Application (Cancer Treatment, Cancer Pain, Noncancer Pain, Spasticity, Analgesia, Mixed Sarcoma and Skin Cancers, Gastric Cancer and Diabetes Mellitus) - Forecast to 2025

Implantable Infusion Pumps Market Analysis & Trends- Application (Cancer Treatment, Cancer Pain, Noncancer Pain, Spasticity, Analgesia, Mixed Sarcoma and Skin Cancers, Gastric Cancer and Diabetes Mellitus) - Forecast to 2025

  • $ 4200
  • Industry report
  • November 2016
  • by Accuray Research LLP

The Global Implantable Infusion Pumps Market is poised to grow at a CAGR of around 6.3% over the next decade to reach approximately $14.33 billion by 2025. Some of the prominent trends that the market ...

Oncology Devices - Medical Devices Pipeline Assessment, 2016

Oncology Devices - Medical Devices Pipeline Assessment, 2016

  • $ 4000
  • Industry report
  • December 2016
  • by Global Data

Oncology Devices - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Oncology Devices - Medical Devices Pipeline Assessment, 2016" provides an overview of ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in Europe

  • January 2017
    10 pages
  • Cancer  

  • Europe  

View report >

Cancer Statistics in the UK and Ireland

  • January 2017
    7 pages
  • Cancer  

  • United Kingdom  

    Ireland  

View report >

Cancer Statistics in the US

  • January 2017
  • Cancer  

  • United States  

View report >

Related Market Segments :

Skin Cancer

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.